University of Oxford
Nuffield Department of Clinical Neurosciences
Selene completed her studies in biochemistry and translational neurology and joined Dr Laura Parkkinen's research group at Oxford to pursue her PhD. The aim of her project is to characterize the a-synuclein strains in order to understand how they might account for distinct clinical and pathological outcomes in different synucleinopathies. Her study also focuses on using RT-QuIC to not only assess its diagnostic value, but also to generate end-point fibrils for extensive characterization of the a-synuclein strains.

Presenter of 1 Presentation

STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF BRAIN DERIVED Α-SYNUCLEIN FIBRILS FROM PD AND MSA

Session Type
SYMPOSIUM
Date
Thu, 17.03.2022
Session Time
02:45 PM - 04:45 PM
Room
ONSITE: 114
Lecture Time
04:00 PM - 04:15 PM

Abstract

Aims

Parkinson’s disease (PD) and multiple system atrophy (MSA) are characterized by the accumulation of filamentous α-synuclein in the brain. However, limited studies have scrutinized the brain derived α-synuclein fibrils and examined how these differ from the fibrils generated with seeding amplification assay like real-time quaking induced conversion (RT-QuIC). Here, we characterize the structural and biochemical properties of the human α-synuclein fibrils. Also, we compare the properties between the human and RT-QuIC amplified fibrils.

Methods

We extracted α-synuclein fibrils from the PD and MSA brains and in parallel generated RT-QuIC amplified fibrils. The morphology of the fibrils was observed using transmission electron microscopy (TEM) and immunogold TEM with antibodies targeting different regions of α-synuclein. Also, biochemical characterization was performed using slot-blot with the same set of antibodies. These observations were further examined with the clinical and neuropathological information.

Results

PD α-synuclein fibrils displayed two structurally distinct TEM morphologies, which were ‘straight’ and ‘twisted’. On the other hand, MSA α-synuclein fibrils were only composed of ‘straight’ fibrils. Furthermore, immunogold antibodies showed different labelling patterns with the α-synuclein fibrils, which provided structural information about the exposed and embedded regions of the fibrils. Also using the slot-blot, we were able to identify different α-synuclein species in the PD and MSA cases.

Conclusions

PD and MSA α-synuclein fibrils showed distinct structural and biochemical characteristics. This finding might provide a further insight about the mechanism on how the α-synuclein strains associate with different synucleinopathies and the causal link to the clinical and neuropathological variability, especially in PD.

Hide